Delivery Order SPE2DB22D1017-SPE2DB24FG4CU
Award Date
8/28/24
Potential Completion Date
8/29/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of 4,565,923,013 units of Tamsulosin HCl 0.4 mg capsules. The award, valued at $3,760.29, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of Amerisourcebergen for pharmaceutical and medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of September 25, 2024. Amerisourcebergen, a large pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,572.06 Firm Fixed Price Delivery Order is for the supply of 4,561,952,911 units of Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of August 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,148.70 firm fixed price delivery order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat benign prostatic hyperplasia. The award has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,507.01 firm fixed-price delivery order is for the supply of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules. The award is not associated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,562,450,566 units of the generic drug Tamsulosin HCL 0.4 mg capsules. The $2,467.32 firm fixed-price delivery order has an ultimate completion date of October 12, 2023. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,423.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,178,585 units of Tamsulosin HCl 0.4 mg capsules and has an ultimate completion date of October 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $4,787.98 contract is for the delivery of 1,000 capsules of the medication Tamsulosin HCL 0.4 mg. This is a firm fixed-price delivery order contract with a completion date of November 13, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,062.27 fixed-price contract is for the supply of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules. The contract has a completion date of September 20, 2023 and is not designated with a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,999.97, is a Firm Fixed Price Delivery Order for the supply of 4,562,926,785 units of Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of November 29, 2023. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, SPE2DX15D7055|SPE2DX24F2ULK, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,224.95, is for the supply of 4,565,944,281 units of Tamsulosin HCl 0.4 mg capsules to support military treatment facilities and programs. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a...